Beta‐Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF ‐ κB Pathways
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8413 ↗At a glance
Journal article in Phytotherapy Research, 2025. Written by Hui-Wen Chan and 3 co-authors. Institution: Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan. Major MEDLINE topics: Polycyclic Sesquiterpenes, Apoptosis, PPAR gamma, Glioblastoma. Cited 5 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Yen Tjing Ling Medical Foundation, Cathay General Hospital, Far Eastern Memorial Hospital-National Yang Ming University Joint Research Program.
Abstract (original language)
Glioblastoma multiforme (GBM) is a highly aggressive brain malignancy with limited treatment options. Radiotherapy (RT) is often used for treating unresectable GBM; however, the outcomes are often limited due to the radioresistance of GBM. Therefore, the discovery of potential radiosensitizers to enhance GBM responses to RT is crucial. Beta‐caryophyllene (BCP), a natural cannabinoid, promotes cancer apoptosis by upregulating the PPARγ signaling pathway and can cross the blood–brain barrier due to its lipophilic nature. This study aimed to evaluate the radiosensitizing potential of BCP in GBM cells. U87MG and GL261 cells and a GL261 tumor‐bearing model were treated with RT, BCP, or both. Treatment efficacy was assessed using the MTT assay and tumor growth tracking, and the underlying mechanisms were investigated using western blotting, immunofluorescence staining, and other analyses. BCP synergistically enhanced the efficacy of RT in cell culture, as evidenced by the combination index determined through the MTT assay. This enhancement was mediated by the BCP‐induced deceleration of DNA damage repair, as demonstrated by sustained γH2AX signal, upregulated PPARγ levels, and reduced expression of pAKT, pERK, and NF‐κB, indicating apoptosis induction and inhibition of survival pathways. BCP significantly inhibited tumor growth in GL261 tumor‐bearing mice with no discernible side effects. These findings indicate that BCP may serve as a potential radiosensitizer for improving RT outcomes in GBM by inhibiting DNA repair, inducing apoptosis, and suppressing anti‐apoptotic and survival pathways.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Radiology, Cathay General Hospital, Taipei City, Taiwan.
- School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
- Division of Radiation Oncology, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
ORCID profiles: Hui-Yen Chuang
Funding
- Yen Tjing Ling Medical Foundation
- Cathay General Hospital
- Far Eastern Memorial Hospital-National Yang Ming University Joint Research Program
Cite
APA
Chan, H. W., Lin, W. C., Kuo, D. Y., & Chuang, H. Y. (2025). Beta‐Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF ‐ κB Pathways. Phytotherapy Research. https://doi.org/10.1002/ptr.8413
Vancouver
Chan HW, Lin WC, Kuo DY, Chuang HY. Beta‐Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF ‐ κB Pathways. Phytotherapy Research. 2025. doi:10.1002/ptr.8413
BibTeX
@article{Chan2025,
author = {Chan, Hui-Wen and Lin, Wei-Chan and Kuo, Deng-Yu and Chuang, Hui-Yen},
title = {Beta‐Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF ‐ κB Pathways},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8413}
}
EUVIMED